Table 2.
Patient characteristics at the initiation of OWHD-DT
| Characteristic | Total n = 112 |
|---|---|
| Age (yr) | 63 (53–69) |
| Men, n (%) | 80 (71.4) |
| Diseases, n (%) | |
| Chronic glomerulonephritis | 38 (33.9) |
| Diabetic nephropathy | 38 (33.9) |
| Nephroscrelosis | 22 (19.6) |
| Polycystic kidney | 9 (8.0) |
| Urological disease | 3 (2.7) |
| Chronic interstitial nephritis | 2 (1.8) |
| Pretreatment, n (%) | |
| Conservative therapy | 97 (86.6) |
| Twice-weekly hemodialysis | 14 (12.5) |
| Thrice-weekly hemodialysis | 1 (0.9) |
| Vascular access, A-V fistula, n (%) | 112 (100) |
| Medications, n (%) | |
| Duretics | 107 (95.5) |
| Erythropoesis stimulating agent | 111 (99.1) |
| Antihypertensives | 87 (77.7) |
| Phosphate binders | 84 (75.0) |
| Activated vitamin D | 89 (79.5) |
| Alkalizing agents | 62 (55.3) |
| K+ ion-exchange resin | 15 (13.3) |
OWHD-DT, Once-weekly hemodialysis combined with dietary treatment